Prelude Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.26M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $218K | Buy |
|
|||||
|
2020
Q1 | $147K | Sell |
|
|||||
|
2019
Q4 | $482K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $7K | Sell |
|
|||||
|
2019
Q1 | $1.27M | Buy |
|
|||||
|
2018
Q4 | $511K | Sell |
|
|||||
|
2018
Q3 | $2.04M | Sell |
|
|||||
|
2018
Q2 | $2.66M | Sell |
|
|||||
|
2018
Q1 | $3.09M | Buy |
|
|||||
|
2017
Q4 | $1.91M | Buy |
|
|||||
|
2017
Q3 | $858K | Buy |
|
|||||
|
2017
Q2 | $778K | Sell |
|
|||||
|
2017
Q1 | $1.06M | Sell |
|
|||||
|
2016
Q4 | $1.16M | Sell |
|
|||||
|
2016
Q3 | $2.46M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $343K | Buy |
|